By the end of the forecast period, the global bioceramics and hydroxyapatite market size is projected to reach a value of USD 4,390.1 Million, recording a CAGR of 6.9%. Future Market Insights delivers key insights on the global bioceramics and hydroxyapatite industry in its latest report titled ‘Bioceramics and Hydroxyapatite market: Global Industry Analysis 2014 to 2018 and Opportunity Assessment 2022 to 2028.’ Sales revenue of bioceramics and hydroxyapatite is expected to be nearly USD 2,243.8 Million in 2018.
Bioceramics are also known as medical ceramics as they are mainly used as an important component in the production of dental and orthopedic implants. Bioceramics materials are mostly oxides, carbides, or nitrides-based. Preference for bioceramics continues to persist and they can be distinguished as biologically active, inert, or resorbable depending on the material type. Aluminum oxide, zirconia, calcium phosphate (tricalcium phosphate, hydroxyapatite), and bioglass are witnessed to be some of the commonly used bioceramics across industries. Hydroxyapatite is a calcium phosphate bioceramic and is biologically active by nature. The natural human bone comprises 70% hydroxyapatite. Thus it has excellent biocompatibility. Hydroxyapatite also aids in bone growth and promotes bone health. However, the low mechanical strength of hydroxyapatite has constrained the application of hydroxyapatite to coat the metal implants to trick the body as the tissues will directly come in contact with bioceramics and hydroxyapatite instead of metal. Thus the implants can gain the strength of the metal and biological acceptability of bioceramics and hydroxyapatite.
To offer effective solutions for bone growth, healthcare institutions prefer investing in hydroxyapatite as they interact with the living tissues of the body. The growing use of hydroxyapatite in the healthcare industry has broadened the scope of market growth for the global bioceramics and hydroxyapatite market. The global bioceramics and hydroxyapatite market witnessed a Y-o-Y growth of 5.7% in 2017. By 2018-end, the global sales of bioceramics and hydroxyapatite are estimated to be valued at US$ 2,243.8 Million. Of various regions, North America and Europe is estimated to account for a value share of approximately 60% in the global bioceramics and hydroxyapatite market by 2018 end, and it is anticipated to show moderate growth for bioceramics and hydroxyapatite from dental and orthopedic implants and other applications.
The growing need for developing effective dental implants, hip, joints, and knee replacement devices is projected to fuel demand for bioceramics and hydroxyapatite over the forecast period. Production of implants per capita has further translated to exponential market growth over the past decade.
There has been an increase in the percentage of the aging population which is prone to greater risk of diseases such as osteoarthritis, knee, joint and hip problems, and tooth decay amongst others. The aging population coupled with other factors such as an increasing number of accidents, and bad eating habits leading to tooth decay amongst others is projected to drive the demand for bioceramics and hydroxyapatite over the forecast period.
Attributed to enhanced biocompatibility, high mechanical strength, and chemical and thermal stability, bioceramics and hydroxyapatite are increasingly being used for orthopedic and dental implants. Growing health concerns pertaining to the impact of the materials used for developing dental implants have led manufacturers to direct their investments toward utilizing titanium as an important component. However, lack of maintenance of titanium implants can result in corrosion of the implants. To offer improved patient care, the manufacturers are developing zirconia-based implants that are white-colored ceramic material. These implants offer improved biocompatibility and are likely to encourage demand for bioceramics and hydroxyapatite in the healthcare industry.
Contrary to the factors boosting the market growth, the availability of bioceramics and hydroxyapatite at premium prices and lack of awareness among consumers is likely to inhibit the growth of the global bioceramics and hydroxyapatite market over the coming years. Also, lack of technological advancements in developing countries of the Asia Pacific region there has still been the prevalence of metal-based implants which may hinder the bioceramics and hydroxyapatite market growth in the long run.
To remain at the forefront of the competitive market, leading market players are focusing on long-term partnerships with implant manufacturers, and expanding their regional footprints in the bioceramics and hydroxyapatite market. In-depth research and development have also been conducted for developing 3-D printing and artificial bones thus expanding the application area and product offerings for bioceramics and hydroxyapatite.
Segmentation Analysis
- On the basis of material type, the aluminium oxide segment is projected to retain its dominance in the global bioceramics and hydroxyapatite market throughout the forecast period, accounting for a value share of ~45% by the end of 2018.
- On the basis of type, bio-inert is expected to remain a leading segment in the global bioceramics and hydroxyapatite market, recording a CAGR of 6.8% over the forecast period. However, the bio-active segment is expected to witness a higher growth rate in terms of value.
- On the basis of application, sales of bioceramics and hydroxyapatite are likely to remain concentrated for the development of the orthopedic implants. However, other applications such as dental implants and implantable electronic devices are projected to witness significant growth over the coming years in terms of consumption.
Vendor Insights
The report highlights some of the top companies operating in the global bioceramics and hydroxyapatite market, which include
- Morgan Technical Ceramics
- CeramTec
- Berkeley Advanced Biomaterials, Inc.
- Kyocera Corporation
- Cam Bio Ceramics BV
- FLUIDINOVA
- Premier Biomaterials
- Plasma Biotal Ltd.
- SofSera
- Bone support AB
- Nano Interface Technology
- Sigma Graft
Global Bioceramics and Hydroxyapatite Market Segmentation
To understand and assess opportunities in the global bioceramics and hydroxyapatite Market, we have divided the report into three sections based on market segmentation as under:
By Material Type
- Aluminium Oxide
- Zirconia
- Calcium Phosphate
- Others
By Type
- Bio-Inert
- Bio-Active
- Bio-Resorbable
By Application
- Dental Implants
- Orthopaedic Implants
- Implantable Electronic Devices
- Others
By Region
- North America
- Latin America
- Eastern Europe
- Western Europe
- SEA and Pacific
- China
- India
- Japan
- MEA
Source: Bioceramics and Hydroxyapatite Market to Witness Steady Growth at 6.9% CAGR by 2028
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Join us as we commemorate 10 years of delivering trusted market insights. Reflecting on a decade of achievements, we continue to lead with integrity, innovation, and expertise.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
